e-learning resources

Inhaled therapy, cardiovascular risk and benefit–risk considerations in COPD: innocent until proven guilty, or vice versa?

Lucile Regard, Pierre-Régis Burgel, Nicolas Roche

Source: Eur Respir J, 61 (2) 2202135; 10.1183/13993003.02135-2022
Journal Issue: February

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Lucile Regard, Pierre-Régis Burgel, Nicolas Roche. Inhaled therapy, cardiovascular risk and benefit–risk considerations in COPD: innocent until proven guilty, or vice versa?. Eur Respir J, 61 (2) 2202135; 10.1183/13993003.02135-2022

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.